Polatuzumab Vedotin-piiq and Secukinumab

• Generic Name: polatuzumab vedotin
• Dosage Forms: n.a.
• Other Brand Names: Polivy

Polatuzumab vedotin-piiq is a CD79b-directed antibody–drug conjugate indicated in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, after at least two prior therapies.

Accelerated approval was granted for this indication based on complete response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

• Generic Name: secukinumab
• Dosage Forms: n.a.
• Other Brand Names: Cosentyx, Cosentyx Sensoready Pen

Secukinumab is an immunosuppressant that is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, or active ankylosing spondylitis.

Secukinumab may also be used for purposes not listed in this medication guide.